We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-2.03%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.68B
AUM Growth
-$7.95M
Cap. Flow
+$55.2M
Cap. Flow %
3.28%
Top 10 Hldgs %
17.16%
Holding
515
New
107
Increased
139
Reduced
156
Closed
69

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$46.2M
2
RACE icon
Ferrari
RACE
+$26.2M
3
DINO icon
HF Sinclair
DINO
+$10.4M
4
PFE icon
Pfizer
PFE
+$10.1M
5
FTI icon
TechnipFMC
FTI
+$9.95M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$51.3M
2
MTD icon
Mettler-Toledo International
MTD
+$37.2M
3
ADSK icon
Autodesk
ADSK
+$26M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$25.6M
5
TRMB icon
Trimble
TRMB
+$12.5M

Sector Composition

Rank Sector Weight
1 Healthcare 24.95%
2 Technology 20.52%
3 Consumer Discretionary 16.46%
4 Industrials 8.03%
5 Financials 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIG icon
26
American International
AIG
$41.9B
$10.3M 0.61%
185,700
-8,220
-4% -$454K
UAA icon
27
Under Armour
UAA
$3B
$10.2M 0.61%
513,500
+122,044
+31% +$2.69M
HD icon
28
Home Depot
HD
$332B
$10.2M 0.6%
43,807
+7
+0% +$1.53K
DHI icon
29
D.R. Horton
DHI
$41B
$10.2M 0.6%
+192,750
New +$9.2M
IQV icon
30
IQVIA
IQV
$34.7B
$10.2M 0.6%
68,000
-8
-0% -$1.25K
A icon
31
Agilent Technologies
A
$39.1B
$10.2M 0.6%
132,519
+8
+0% +$577
PH icon
32
Parker-Hannifin
PH
$125B
$10.1M 0.6%
+55,809
New +$9.49M
RMD icon
33
ResMed
RMD
$28.3B
$10M 0.6%
74,305
-5,095
-6% -$668K
NKE icon
34
Nike
NKE
$61.9B
$9.92M 0.59%
105,659
+39
+0% +$3.34K
BIIB icon
35
Biogen
BIIB
$29.9B
$9.89M 0.59%
42,500
– –
ORLY icon
36
O'Reilly Automotive
ORLY
$72.4B
$9.85M 0.58%
370,560
+60
+0% +$1.55K
COP icon
37
ConocoPhillips
COP
$147B
$9.84M 0.58%
+172,600
New +$9.82M
ALNY icon
38
Alnylam Pharmaceuticals
ALNY
$36.3B
$9.82M 0.58%
122,113
-16,687
-12% -$1.32M
P
39
Everpure Inc
P
$24.8B
$9.75M 0.58%
575,647
-32,253
-5% -$506K
COUP
40
DELISTED
Coupa Software Incorporated
COUP
$9.73M 0.58%
75,096
-462
-0.6% -$64K
MNST icon
41
Monster Beverage
MNST
$91.4B
$9.63M 0.57%
331,802
+2
+0% +$61
VTRS icon
42
Viatris
VTRS
$20.1B
$9.62M 0.57%
486,200
-142,300
-23% -$2.79M
FTI icon
43
TechnipFMC
FTI
$30.6B
$9.58M 0.57%
+533,423
New +$9.95M
WAT icon
44
Waters Corp
WAT
$36.8B
$9.58M 0.57%
42,914
+30,883
+257% +$6.67M
AZO icon
45
AutoZone
AZO
$48.3B
$9.56M 0.57%
8,813
-4,195
-32% -$4.7M
REGN icon
46
Regeneron Pharmaceuticals
REGN
$68.8B
$9.54M 0.57%
34,405
+6,398
+23% +$1.89M
VLO icon
47
Valero Energy
VLO
$89.8B
$9.54M 0.57%
+111,904
New +$9.05M
TMO icon
48
Thermo Fisher Scientific
TMO
$211B
$9.47M 0.56%
32,509
+9
+0% +$2.58K
PFE icon
49
Pfizer
PFE
$140B
$9.43M 0.56%
+276,658
New +$10.1M
STNE icon
50
StoneCo
STNE
$2.62B
$9.42M 0.56%
+270,868
New +$9.03M
1
2
3 4 5

Similar funds

ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
WAS
Wesleyan Assurance Society Birmingham, United Kingdom $1.69B AUM 28.38% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PDT Partners's Q3 2019 Portfolio in Review

As of Q3 2019, PDT Partners held 515 positions worth $1.68B, down 0.47% from $1.69B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

PDT Partners deployed $55.2M of net new capital in Q3 2019, opening 107 new positions and adding to 139 existing holdings. Its largest new stake was Linde: 238,663 shares worth $46.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was AbbVie, an estimated $51.3M trimmed.

  • PDT Partners's largest Q3 2019 buy was Linde: 238,663 shares worth $46.2M.
  • PDT Partners added most to Ferrari in Q3 2019, an estimated $26.2M increase.
  • PDT Partners's biggest Q3 2019 reduction was AbbVie, cutting an estimated $51.3M.
  • PDT Partners fully exited Mettler-Toledo International in Q3 2019, selling an estimated $37.2M.
  • PDT Partners's ten largest holdings make up 17% of its $1.68B portfolio in Q3 2019.
  • PDT Partners opened 107 new positions and closed 69 in Q3 2019.
  • PDT Partners's portfolio value fell 0.47% quarter-over-quarter to $1.68B.

Based on PDT Partners's 13F filing for Q3 2019, filed 14 Nov 2019.